Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHays Regulatory News (HAS)

Share Price Information for Hays (HAS)

Share Price is delayed by 15 minutes
Get Live Data
35.44    0.00 (0.00%)
Bid:
34.48
Ask:
36.00
Spread: 1.52 (4.408%)
Market Cap: £564.67m
HAS Live PriceLast checked at - London Stock Exchange

Intraday Hays Share Chart

Share Buyback Programme

24 Feb 2023 07:00

RNS Number : 8971Q
Hays PLC
24 February 2023
 

 

FOR IMMEDIATE RELEASE

 

24 February 2023

Hays plc

Share Buyback Programme

On 20 June 2022, Hays plc (the "Company") announced that it had entered into a non-discretionary arrangement with Jefferies International Limited ("Jefferies") in relation to the programme to repurchase the Company's ordinary 1 pence shares up to the value of c.£63million.

In the six months ending 31 December 2022, 50.2million shares were purchased and cancelled, at a cost of £57.6million. On 23 February 2023, the Company entered into a further agreement with Jefferies in relation to the purchase by Jefferies of ordinary shares up to the value of £18,200,000. The programme will be executed by Jefferies from the date of this announcement and will end no later than 30 June 2023.

As announced on 28 April 2022, the purpose of the programme is to reduce the total issued share capital of the Company. Jefferies will purchase the Company's ordinary shares as principal and sell them on to the Company in accordance with the terms of their engagement. The Company intends to cancel the shares it purchases through the programme.

Any share purchases will be made in accordance with certain pre-set parameters set out in the terms of Jefferies engagement, the general authority of the Company to repurchase shares granted by shareholders at the Company's annual general meeting held on 9 November 2022 (which permits the Company to purchase no more than 162,523,118 of the Company's ordinary shares, taking into account the amount of shares already repurchased using this authority under the buyback programmes announced on 23 September 2020, 29 November 2021 and 28 April 2022), the EU Market Abuse Regulation (596/2014) as it applies in the UK, the Commission Delegated Regulation (2016/1052) as it applies in the UK and Chapter 12 of the Financial Conduct Authority's Listing Rules.

 

For further information please contact:

David Phillips, Head of Investor Relations and ESG on +44 (0) 333 010 7122, or ir@hays.com

LEI code: 213800QC8AWD4BO8TH08

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSNKNBBPBKDKBB
Date   Source Headline
13th Jan 20167:00 amRNS2nd Quarter Update
31st Dec 20159:00 amRNSTotal Voting Rights
15th Dec 20157:00 amRNSDirectorate Change
14th Dec 20153:08 pmRNSHolding(s) in Company
30th Nov 20154:20 pmRNSHolding(s) in Company
30th Nov 20152:18 pmRNSTotal Voting Rights
12th Nov 20152:51 pmRNSDirector/PDMR Shareholding
11th Nov 20154:16 pmRNSResult of AGM
11th Nov 20154:14 pmRNSDirectorate Change
11th Nov 20153:39 pmRNSDirector/PDMR Shareholding
6th Nov 20157:15 amRNSTreasury Stock
30th Oct 201510:33 amRNSTotal Voting Rights
19th Oct 201510:15 amRNSDirector Declaration
8th Oct 20157:00 amRNS1st Quarter Update
1st Oct 20154:45 pmRNSAnnual Financial Report
30th Sep 201510:55 amRNSTotal Voting Rights
10th Sep 20151:12 pmRNSDirector/PDMR Shareholding
8th Sep 201512:15 pmRNSDirector/PDMR Shareholding
4th Sep 201511:03 amRNSDirector/PDMR Shareholding
28th Aug 201510:57 amRNSTotal Voting Rights
27th Aug 20157:00 amRNSFinal Results
6th Aug 20152:28 pmRNSBlocklisting Interim Review
31st Jul 201510:06 amRNSTotal Voting Rights
16th Jul 20154:38 pmRNSDirector Declaration
9th Jul 20157:00 amRNSTrading Update
30th Jun 201511:29 amRNSTotal Voting Rights
1st Jun 20151:54 pmRNSTotal Voting Rights
28th May 201510:00 amRNSDirector Declaration
27th May 201510:00 amRNSDirector/PDMR Shareholding
21st May 201510:06 amRNSDirector/PDMR Shareholding
1st May 201510:26 amRNSDirector/PDMR Shareholding
30th Apr 201510:17 amRNSTotal Voting Rights
10th Apr 20157:00 amRNSInterim Management Statement
1st Apr 20152:44 pmRNSSharesave Grant
31st Mar 201511:58 amRNSTotal Voting Rights
23rd Mar 201510:08 amRNSDirector/PDMR Shareholding
20th Mar 201510:13 amRNSDirector/PDMR Shareholding
27th Feb 20153:21 pmRNSHolding(s) in Company
27th Feb 201510:36 amRNSTotal Voting Rights
25th Feb 20157:03 amRNSDirectorate Change
25th Feb 20157:00 amRNSHalf Yearly Report
30th Jan 201511:02 amRNSTotal Voting Rights
8th Jan 20157:00 amRNSTrading Update
31st Dec 201410:00 amRNSTotal Voting Rights
4th Dec 20147:00 amRNSAcquisition of Veredus Corp. in the US
1st Dec 20149:26 amRNSTotal Voting Rights
17th Nov 201410:04 amRNSDirector/PDMR Shareholding
12th Nov 20144:57 pmRNSResult of AGM
12th Nov 20143:32 pmRNSDirectorate Change
31st Oct 20143:24 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.